Grufity logo
Grufity logo

Latest Lynx1 Capital Management LP Stock Portfolio

$632Million | No. of Holdings #23

Lynx1 Capital Management LP Performance

2026 Q1+12.51%
YTD+12.51%
2025+63.54%

About Lynx1 Capital Management LP and 13F Hedge Fund Stock Holdings

Lynx1 Capital Management LP is a hedge fund based in San Juan, PR. On 2026-05-04, the fund reported it's updated stock portfolio. In the 13F Holdings report, Lynx1 Capital Management LP reported an equity portfolio of $632.7 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Lynx1 Capital Management LP are STOK, GHRS, CGEM. The fund has invested 24.5% of it's portfolio in STOKE THERAPEUTICS INC and 23.9% of portfolio in GH RESEARCH PLC. <br><br> The fund managers got completely rid off ARROWHEAD PHARMACEUTICALS IN (ARWR), MAPLIGHT THERAPEUTICS INC and GENERATION BIO CO (GBIO) stocks. They significantly reduced their stock positions in IMMATICS N.V (IMTX), XENCOR INC (XNCR) and STOKE THERAPEUTICS INC (STOK). Lynx1 Capital Management LP opened new stock positions in VYNE THERAPEUTICS INC (VYNE), IBIO INC (IBIO) and BOLT BIOTHERAPEUTICS INC (BOLT). The fund showed a lot of confidence in some stocks as they added substantially to AGIOS PHARMACEUTICALS INC (AGIO), ENTRADA THERAPEUTICS INC (TRDA) and KORRO BIO INC.
Lynx1 Capital Management LP Equity Portfolio Value
Last Reported on: 04 May, 2026
$632Million
  as of May 04, 2026

Lynx1 Capital Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Lynx1 Capital Management LP made a return of 12.51% in the last quarter. In trailing 12 months, it's portfolio return was 112.11%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
vyne therapeutics inc973,148
ibio inc129,344
bolt biotherapeutics inc124,432
absci corporation63,735
traws pharma inc27,593
New stocks bought by Lynx1 Capital Management LP

Additions

Ticker% Inc.
agios pharmaceuticals inc3,179
entrada therapeutics inc309
korro bio inc126
design therapeutics inc71.93
denali therapeutics inc8.14
gh research plc3.43
werewolf therapeutics inc0.28
neuphoria therapeutics inc0.01
Additions to existing portfolio by Lynx1 Capital Management LP

Reductions

Ticker% Reduced
immatics n.v-76.47
xencor inc-23.98
stoke therapeutics inc-11.86
c4 therapeutics inc-1.4
precision biosciences inc-0.89
Lynx1 Capital Management LP reduced stake in above stock

Sold off

Ticker$ Sold
applied therapeutics inc-41,050
generation bio co-142,000
maplight therapeutics inc-236,724
arrowhead pharmaceuticals in-799,535
Lynx1 Capital Management LP got rid off the above stocks

Sector Distribution

Lynx1 Capital Management LP has about 72.1% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare72.1
Others27.9

Market Cap. Distribution

Lynx1 Capital Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • SMALL-CAP
  • UNALLOCATED
  • MID-CAP
  • MICRO-CAP
Category%
SMALL-CAP60.3
UNALLOCATED27.9
MID-CAP5.7
MICRO-CAP5.1

Stocks belong to which Index?

About 66% of the stocks held by Lynx1 Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200066
Others34
Top 5 Winners (%)%
cg oncology inc
63.0 %
CCCC
c4 therapeutics inc
37.4 %
CGEM
cullinan therapeutics inc
37.3 %
DTIL
precision biosciences inc
32.1 %
HOWL
werewolf therapeutics inc
31.4 %
Top 5 Winners ($)$
CGEM
cullinan therapeutics inc
34.6 M
GHRS
gh research plc
14.4 M
AGIO
agios pharmaceuticals inc
8.9 M
CCCC
c4 therapeutics inc
5.1 M
DNLI
denali therapeutics inc
4.9 M
Top 5 Losers (%)%
PASG
passage bio inc
-33.5 %
PRQR
proqr thrapeutics n v
-19.8 %
XNCR
xencor inc
-18.7 %
IMTX
immatics n.v
-3.9 %
Top 5 Losers ($)$
PASG
passage bio inc
-2.5 M
XNCR
xencor inc
-2.0 M
IMTX
immatics n.v
-0.4 M
PRQR
proqr thrapeutics n v
0.0 M

Lynx1 Capital Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Lynx1 Capital Management LP

Lynx1 Capital Management LP has 23 stocks in it's portfolio. About 97.1% of the portfolio is in top 10 stocks. PASG proved to be the most loss making stock for the portfolio. CGEM was the most profitable stock for Lynx1 Capital Management LP last quarter.

$632.72MTotal Value
27.00Positions
04 May, 2026Last Reported
Current holdings of Current Stock Holdings of Lynx1 Capital Management LP, last reported on 04 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
GHRS
Gh Research Plc

Gh Research Plc

GHRS
Lynx1 Capital Management LP's holding in Gh Research Plc over time
23.92%10,763,300
$151.33M
23.92%
increased 3.43 percentadded
IMTX
Immatics N.V

Immatics N.V

IMTX
Lynx1 Capital Management LP's holding in Immatics N.V over time
0.34%216,973
$2.14M
0.34%
decreased 76.47 percentreduced
PRQR
Proqr Thrapeutics N V

Proqr Thrapeutics N V

PRQR
Lynx1 Capital Management LP's holding in Proqr Thrapeutics N V over time
0.02%68,486
$110.9K
0.02%
unchanged 0 percentunchanged